Dermira Revenue and Competitors

Claim your profile

Location

$599.3M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Dermira's estimated annual revenue is currently $42.3M per year.(i)
  • Dermira received $250.0M in venture funding in May 2017.
  • Dermira's estimated revenue per employee is $882,063
  • Dermira's total funding is $599.3M.

Employee Data

  • Dermira has 48 Employees.(i)
  • Dermira grew their employee count by -54% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4.7M619%$53MN/A
#2
$34.3M17717%$110MN/A
#3
$0.4M2735%$236.7MN/A
#4
$34.5M178-5%$160MN/A
#5
$3.7M2420%N/AN/A
#6
$147.3M3212%$192.5MN/A
#7
$17.5M113-3%$24.1MN/A
#8
$2.7M4379%N/AN/A
#9
$34.1M220100%N/AN/A
#10
$47.1M304-3%N/AN/A

Dermira is a biopharmaceutical company dedicated to bringing biotech ingenuity to medical dermatology by delivering differentiated, new therapies to the millions of patients living with chronic skin conditions. We are committed to understanding and addressing the needs of both patients and physicians, and using our experience and insight to identify and develop leading-edge medical dermatology clinical programs. Our goal is to help transform the way skin conditions are treated by serving as the bridge between unmet patient needs and the significant scientific advances being made in understanding skin biology. Learn more about who we are and what we do by visiting Dermira.com. Here are our community guidelines: https://bit.ly/2rH5IuL

keywords:Biotechnology,Enterprise Software,Health It,Healthcare,Pharmaceuticals

$599.3M

Total Funding

48

Number of Employees

$42.3M

Revenue (est)

-54%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Dermira News

2022-04-20 - Acne Vulgaris Treatment Market Size, Outlook And Forecast ...

Common Pharma Inc, Cutanea Life Sciences Inc, Dermira Inc, ELORAC Inc, Ensol Biosciences Inc, Foamix Pharmaceuticals Ltd, Galderma SA, GlaxoSmithKline Plc,...

2022-04-17 - Tom Wiggans to receive KU Pharmacy Distinguished Service ...

Wiggans then co-founded Dermira Inc., a biotech firm in Menlo Park, California. As CEO and director, Wiggans helped make Dermira an...

2022-03-22 - Cala Health Expands Leadership Team to Fuel Growth and ...

Prior to UCB, Jeron served as Senior Vice President of Commercial Operations at Dermira, Inc., a fully integrated specialty pharmaceutical...

2020-01-13 - Eli Lilly acquires skin disease-focused Dermira in $1.1B deal

Dermira has one approved product, Qbrexza (glycopyrronium), a medicated cloth used to treat primary axillary hyperhidrosis, or excessive underarm sweating. The lead product candidate in its pipeline is lebrikizumab, a monoclonal antibody in Phase III development designed to treat moderate to sev ...

2019-09-08 - Aperio Group LLC Raises Stock Holdings in Dermira Inc (NASDAQ:DERM)

Aperio Group LLC boosted its holdings in shares of Dermira Inc (NASDAQ:DERM) by 24.4% during the second quarter, according to its most ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$5.1M4841%$69M
#2
$5.6M484%N/A
#3
$8M48109%N/A
#4
$15M490%N/A
#5
$8.2M49-25%N/A

Dermira Funding

DateAmountRoundLead InvestorsReference
2011-10-21$42.0MAArticle
2013-06-12$35.0MBMaruho Co LtdArticle
2014-08-20$51.0MCMultipleArticle
2015-08-06$UndisclosedUndisclosedLeerink Partners LLC,Article
2016-09-16$1.5MUndisclosedArticle
2017-03-03$168.5MUndisclosedMultipleArticle
2017-03-09$193.8MUndisclosedLeerink Partners LLC,Article
2017-05-11$250.0MUndisclosedArticle